Lumexa Imaging Holdings, Inc. Common Stock (LMRI) vs Latigo Biotherapeutics Inc. (LTGO)

A side-by-side comparison of Lumexa Imaging Holdings, Inc. Common Stock and Latigo Biotherapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LMRI

Lumexa Imaging Holdings, Inc. Common Stock

$1.02B

$10.65HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT

LTGO

Latigo Biotherapeutics Inc.

$1.01B

$16.79HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT

Total return — LMRI vs LTGO

growth of $100 · dividends reinvested · last 1y

LMRI -5.9% (-5.9%/yr)LTGO -7.6% (-7.6%/yr)LMRI compounded faster over this window

LMRI LTGO

Metrics side by side

LTGO is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full LMRI analysis Full LTGO analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.